Idexx Laboratories IDXX
NASDAQ IDXX
$506.60 -8.55 (-1.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Idexx Laboratories (IDXX) EV to EBITDA (2009 - 2026)

Idexx Laboratories (IDXX) posted EV to EBITDA of 97.11 for Q2 2026, down 20.56% on a QoQ basis from 122.24 in Q1 2026, and down 15.41% year-over-year from 114.79 in Q2 2025.

Analysis

Idexx Laboratories (IDXX) EV to EBITDA (2009 - 2026) Analysis & Trends

Idexx Laboratories has reported EV to EBITDA for 18 years, with the latest figure at 97.11 in Q2 2026.

  • On a quarterly basis, EV to EBITDA fell 15.41% year-over-year to 97.11 in Q2 2026; TTM through Jun 2026 was 28.33, a 16.96% decrease from a year earlier, with the FY2025 full-year figure at 39.52, up 33.31% from the prior year.
  • EV to EBITDA was 97.11 for Q2 2026 at Idexx Laboratories, down from 122.24 in the prior quarter.
  • The five-year high for EV to EBITDA was 186.03 in Q4 2023, with the low at 97.11 in Q2 2026.
  • Average EV to EBITDA over 5 years is 140.43, with a median of 141.93 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2025: EV to EBITDA slumped 52.77% in 2022, then jumped 33.23% in 2025.
  • Over 5 years, EV to EBITDA stood at 148.79 in 2022, then advanced by 25.03% to 186.03 in 2023, then sank by 31.29% to 127.83 in 2024, then jumped by 33.23% to 170.3 in 2025, then plunged by 42.98% to 97.11 in 2026.
  • The last three EV to EBITDA figures came in at 97.11 (Q2 2026), 122.24 (Q1 2026), and 170.3 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 39.99 Bn 39.79 Bn 779.09 Mn
2 Zoetis 30.50 Bn 28.83 Bn 1.05 Bn
3 Elanco Animal Health 11.44 Bn 10.91 Bn 798.00 Mn
4 Phibro Animal Health 1.48 Bn 1.40 Bn 134.40 Mn
5 Immucell 89.38 Mn 80.52 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 74.34 Mn 67.24 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 97.11
Mar 31, 2026 122.24
Dec 31, 2025 170.30
Sep 30, 2025 143.45
Jun 30, 2025 114.79
Mar 31, 2025 106.60
Dec 31, 2024 127.83
Sep 30, 2024 135.37
Jun 30, 2024 150.80
Mar 31, 2024 148.34
Dec 31, 2023 186.03
Sep 30, 2023 130.74
Jun 30, 2023 140.41
Mar 31, 2023 147.64
Dec 31, 2022 148.79
Sep 30, 2022 110.04
Jun 30, 2022 162.77
Mar 31, 2022 184.58
Dec 31, 2021 278.81
Sep 30, 2021 232.97